申请人:Sumitomo Pharmaceuticals Company, Limited
公开号:US05814654A1
公开(公告)日:1998-09-29
A substituted guanidine derivative represented by the general formula: ##STR1## is useful as a therapeutic or prophylactic agent for diseases caused by the acceleration of the sodium/proton (Na.sup.+ /H.sup.+) exchange transport system, for example, hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia or ischemic reperfusion, cerebroischemic disorders, diseases caused by excessive cell proliferation, or diseases caused by endothelial cell injury.
一种以一般式表示的取代胍衍生物:##STR1## 作为一种治疗或预防代理,用于由钠/质子(Na.sup.+ /H.sup.+)交换输运系统加速引起的疾病,例如高血压,心律失常,心绞痛,心脏肥大,糖尿病,与缺血或缺血再灌注相关的器官疾病,脑缺血性疾病,由过度细胞增殖引起的疾病或由内皮细胞损伤引起的疾病。